Owusu Richmond, Kwarteng Emmanuel Bugyei, Bawua Serwaa Akoto, Otoo Desmond Dzidzornu, Nonvignon Justice
Department of Health Policy, Planning and Management, School of Public Health, University of Ghana, Accra, Ghana.
Department of Biological, Environmental, and Occupational Health, School of Public Health, University of Ghana, Accra, Ghana.
Front Public Health. 2024 Nov 19;12:1383743. doi: 10.3389/fpubh.2024.1383743. eCollection 2024.
Clinical studies, particularly in the context of HIV/AIDS, have utilized health-related quality of life (HRQoL) and health state utility values to assess both clinical and economic implications. Improvement in HIV management with antiretroviral therapy (ART) has coincided with an increased morbidity of chronic conditions such as diabetes and hypertension among people living with HIV. The study offers empirical evidence establishing a link between HIV, comorbidities like hypertension and diabetes, and their collective impact on HRQoL.
A cross-sectional quantitative study among 418 HIV patients in three regions of Ghana in the Savannah, Middle Belt, and Coastal belt. Face-to-face interviews were conducted using EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) in combination with EuroQol-Visual Analog Scales (EQ-VAS). Ugandan EQ-5D-5L value set was used for computing the utility values. Patients' socio-demographic and clinical data were obtained from medical records and analyzed descriptively. Mann-Whitney U and Kruskal Wallis tests were used to evaluate the relationship between patient socio-demographic and clinical variables and health status.
Overall median utility value was 0.93(IQR=0.79, 1.00) from the EQ-5D index and 90 (IQR = 80, 100) from the EQ-VAS scores. Prevalence of hypertension and diabetes were 9.1% and 2.4% respectively. There was significant difference in EQ-VAS score between HIV patients with hypertension and those without hypertension (z = 2.146 = 0.032). There was also a significant difference in the EQ-VAS scores (z = 2.381, = 0.017) of patients with diabetes and those without diabetes. Region, sex, age, education, marital status, employment status, place of residence, monthly income level, duration of infection, adherence to ART, and other illness were significantly associated with EQ-5D-5L utility and EQ-VAS scores at 0.05 significant level.
HRQoL among HIV positive individuals in Ghana was high. Comorbidities such as hypertension or diabetes had nuanced effects on perceived health status. A patient-centered, multidisciplinary approach to HIV care should be adopted considering regional differences and the presence of comorbidities.
临床研究,尤其是在艾滋病毒/艾滋病背景下,已利用与健康相关的生活质量(HRQoL)和健康状态效用值来评估临床和经济影响。抗逆转录病毒疗法(ART)改善了艾滋病毒管理,但与此同时,艾滋病毒感染者中糖尿病和高血压等慢性病的发病率有所上升。该研究提供了实证证据,证实了艾滋病毒、高血压和糖尿病等合并症及其对HRQoL的综合影响之间的联系。
在加纳萨凡纳、中部地区和沿海地区的三个地区对418名艾滋病毒患者进行了一项横断面定量研究。使用欧洲五维健康量表-5级(EQ-5D-5L)结合欧洲视觉模拟量表(EQ-VAS)进行面对面访谈。乌干达EQ-5D-5L值集用于计算效用值。患者的社会人口统计学和临床数据从医疗记录中获取并进行描述性分析。使用曼-惠特尼U检验和克鲁斯卡尔-沃利斯检验来评估患者社会人口统计学和临床变量与健康状况之间的关系。
EQ-5D指数的总体中位数效用值为0.93(IQR=0.79,1.00),EQ-VAS评分为90(IQR = 80,100)。高血压和糖尿病的患病率分别为9.1%和2.4%。患有高血压的艾滋病毒患者和未患高血压的患者之间的EQ-VAS评分存在显著差异(z = 2.146, = 0.032)。患有糖尿病的患者和未患糖尿病的患者的EQ-VAS评分也存在显著差异(z = 2.381, = 0.017)。在0.05的显著水平上,地区、性别、年龄、教育程度、婚姻状况、就业状况、居住地点、月收入水平、感染持续时间、对ART的依从性以及其他疾病与EQ-5D-5L效用和EQ-VAS评分显著相关。
加纳艾滋病毒阳性个体的HRQoL较高。高血压或糖尿病等合并症对感知健康状况有细微影响。应采用以患者为中心的多学科艾滋病毒护理方法,同时考虑地区差异和合并症的存在。